# BASAGLAR Tempo Pen

NDC: 0002-8214
Generic name: Insulin glargine
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20151216
Marketing ended: 20260727
FDA application: BLA205692

## Active ingredients

- INSULIN GLARGINE: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-8214"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-8214
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae